These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16306624)

  • 21. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
    Engelhard VH; Lacy E; Ridge JP
    J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.
    McMichael AJ; Gotch FM; Rothbard J
    J Exp Med; 1986 Nov; 164(5):1397-406. PubMed ID: 2430041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
    Wang M; Lamberth K; Harndahl M; Røder G; Stryhn A; Larsen MV; Nielsen M; Lundegaard C; Tang ST; Dziegiel MH; Rosenkvist J; Pedersen AE; Buus S; Claesson MH; Lund O
    Vaccine; 2007 Apr; 25(15):2823-31. PubMed ID: 17254671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
    Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition.
    Collins EJ; Booth BL; Cerundolo V
    J Immunol; 1999 Jan; 162(1):331-7. PubMed ID: 9886403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
    Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
    Voeten JT; Bestebroer TM; Nieuwkoop NJ; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2000 Aug; 74(15):6800-7. PubMed ID: 10888619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin.
    Hioe CE; Hinshaw VS
    J Immunol; 1989 Apr; 142(7):2482-8. PubMed ID: 2466897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.
    Voeten JT; Rimmelzwaan GF; Nieuwkoop NJ; Fouchier RA; Osterhaus AD
    Clin Exp Immunol; 2001 Sep; 125(3):423-31. PubMed ID: 11531950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL.
    Yang S; Linette GP; Longerich S; Roberts BL; Haluska FG
    Cell Immunol; 2000 Aug; 204(1):29-37. PubMed ID: 11006015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes.
    Gould K; Cossins J; Bastin J; Brownlee GG; Townsend A
    J Exp Med; 1989 Sep; 170(3):1051-6. PubMed ID: 2475569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitating presentation of MHC class I-restricted antigens.
    Chen W; Bennink JR; Yewdell JW
    Methods Mol Biol; 2001; 156():245-54. PubMed ID: 11068765
    [No Abstract]   [Full Text] [Related]  

  • 35. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteasomes generate in vitro a natural peptide of influenza-A nucleoprotein functional in HLA-B27 antigen assembly.
    Svensson K; Lévy F; Sundberg U; Boman HG; Hendil KB; Kvist S
    Int Immunol; 1996 Apr; 8(4):467-78. PubMed ID: 8671633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.
    Donnelly JJ; Ulmer JB; Hawe LA; Friedman A; Shi XP; Leander KR; Shiver JW; Oliff AI; Martinez D; Montgomery D
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3530-4. PubMed ID: 7682709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tat-mediated protein delivery can facilitate MHC class I presentation of antigens.
    Moy P; Daikh Y; Pepinsky B; Thomas D; Fawell S; Barsoum J
    Mol Biotechnol; 1996 Oct; 6(2):105-13. PubMed ID: 8970166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction.
    Brémond A; Meynet O; Mahiddine K; Coito S; Tichet M; Scotlandi K; Breittmayer JP; Gounon P; Gleeson PA; Bernard A; Bernard G
    Blood; 2009 Jan; 113(2):347-57. PubMed ID: 18849489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sindbis virus-based vectors for the study of class I antigen presentation in vitro and in vivo.
    Polo JM; Bergmann CC
    Methods Mol Biol; 2001; 156():111-28. PubMed ID: 11068754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.